Hints and tips:
Related Special Reports
...What that shows is that big companies have shied away from doing mega deals but smaller acquisitions have gone ahead as they probably posed less of a threat....
...Finding and assessing prospects in the pharma market takes time, according to Denton, an experienced dealmaker who when working as chief financial officer at pharmacy giant CVS in 2018 oversaw its $68bn...
...“It is not at all clear that Merck is doing anything other than extending its monopoly power over the drug,” Warren said....
...“People were thinking that I’m trying to go into the pharma business [as] window dressing for my tobacco business,” he says. He is accustomed to receiving a frosty reception from scientists....
...for its combined pharmaceuticals and medical device business....
...The chief executives of Pfizer, BioNTech and Moderna have shared more than $100mn in pay during the pandemic reflecting the huge commercial success of the mRNA Covid vaccines developed by their pharmaceutical...
...Regeneron, though, is hardly a mom-and-pop business. It has a market value of $60bn....
...Like all large pharma companies, Merck’s business development team maintains a long list of potential targets, ranging from smaller biotechs with exciting but unproven drugs to larger companies with medicines...
...Investors are being asked to forgo about £60m to avoid doing business with a company whose main product kills people. That would be short-sighted and simplistic....
...The fact that it is now known universally as the Pfizer shot is “the biggest marketing coup in the history of American pharmaceuticals”....
...dismissed fines as a cost of doing business....
...“In 2009-10, pharma companies were priced as if they were going to go out of business, as if they were never going to have a [new] drug again,” he says....
...Yet by 2005, when Rahul Singhvi took over as chief executive, the women’s health business was being derailed by competition and concerns that oestrogen treatments increased the risk of breast cancer....
...Democrats and Republicans have condemned the wider pharmaceutical industry for soaring drug prices, and some have pointed to pay packages, like the $25m Mr Gorsky made in 2019, as a part of the problem....
...But she hopes the sheer fact of people going to prison will deter other drugmakers, which may have previously accepted fines as a cost of doing business....
...J&J is still respected as capable of doing its job — including creating life-saving drugs — but it needs to take action to address questions about its character, he said....
...“That will change the entire pharma model,” he says....
...It said it intended to carry on doing business using cash on hand and operating cash flows to pay employees and fund operations....
...“There is so much talent at Google and under David’s leadership they are doing some really exciting things,” she said....
...“From a public health perspective, criminal charges are important because a fine can be seen by a company as a cost of doing business,” he said....
...But those GSK critics will doubtless worry about the progress in strengthening the pharmaceuticals business and the research and development pipeline in that three-year period....
...It makes no sense to rush a sale of the consumer division before the pharma business gets stronger. Even when the diagnosis is right, successful treatments need careful timing....
...The experiment reflects a shift in the pattern and economics of illness, which has forced big pharma to reconsider business models that have served it well for decades....
...And bigger deals, many argue, could now become the norm in sectors such as pharma, beverages and technology....
...One analyst, who asked not to be named, said they viewed the talks as a direct response to fears that Amazon plans to enter the pharmaceuticals industry by selling drugs online, setting up a PBM, or doing...
International Edition